1. Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases.
- Author
-
Lee, Sung-Bau, Chang, Ting-Yu, Lee, Nian-Zhe, Yu, Zih-Yao, Liu, Chi-Yuan, and Lee, Hsueh-Yun
- Subjects
- *
BIOSYNTHESIS , *TERTIARY amines , *ANTINEOPLASTIC agents , *KINASES , *DNA replication , *NON-small-cell lung carcinoma - Abstract
This study presents the design, synthesis, and characterization of bisindole molecules as anti-cancer agents against Tousled-like kinases (TLKs). We show that compound 2 composed of an indirubin-3′-oxime group linked with a (N -methylpiperidin-2-yl)ethyl moiety possessed inhibitory activity toward both TLK1 and TLK2 in vitro and diminished the phosphorylation level of the downstream substrate anti-silencing function 1 (ASF1) in replicating cells. The treatment of compound 2 impaired DNA replication, slowed S-phase progression, and triggered DNA damage response in replicating cells. Structure optimization further discovered six derivatives exhibiting potent TLK inhibitory activity and revealed the importance of the tertiary amine-containing moiety of the side chain. Moreover, the derivatives 6 , 17 , 19 , and 20 strongly suppressed the growth of triple-negative breast cancer MDA-MB-231 cells, non-small cell lung cancer A549 cells, and colorectal cancer HCT-116 cells, while normal lung fibroblast MRC5 and IMR90 cells showed a lower response to these compounds. Taken together, this study identifies tertiary amine-linked indirubin-3′-oximes as potent anticancer agents that inhibit TLK activity. [Display omitted] • Compound 2 is identified as a lead compound for development of TLK inhibitors. • The derivatives with a tertiary amine-containing side chain potently inhibit TLKs. • The derivatives impair chromatin replication and induce DNA damage response. • The derivatives are highly toxic to cancer cell lines. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF